Brief: Verve Therapeutics' Cash, Cash Equivalents And Marketable Securities Of $485.2 Million With Cash Runway Into 2026
07/11/2023 11:38
Nov 7 (Reuters) - Verve Therapeutics Inc VERV.O :
* VERVE THERAPEUTICS INC - CASH, CASH EQUIVALENTS AND
MARKETABLE
SECURITIES OF $485.2 MILLION WITH CASH RUNWAY INTO 2026
Source text for Eikon: ID:nGNXdx12c
Further company coverage: VERV.O
((Reuters.Briefs@thomsonreuters.com;))